Translational Research and Emerging Therapies
edited by Sanjiv S. Agarwala
Melanoma provides clinicaians and researchers the necessary context and perspective to integrate and effectively deploy cutting-edge therapies into daily practice.
Melanoma includes:
- synthesizes the scientific principles, clinical trial results, and clinical implications of emerging and translational melanoma therapies
- covers the entire range of translational research and therapies, including pathogenesis, progression pathways, immunotherapy, gene therapy, adjuvant therapy, surgical staging, and metastatic disease
- provides context and perspective to enable the clinician to select and use new therapies eggectively and knowledgeably
Contents
- UV Radiation in Melanoma Development and Pathogenesis
- Overview of Molecular Pathways in Melanoma
- Challenging Melanocytic Neoplasms: Spitzoid Melanoma Vs. Spitz Nevus
- Melanoma Genomics-Techniques and Implications
- RAS Signaling in Melanoma Development and Prevention
- Targeting BRAF Activity as a Novel Paradigm for Melanoma Therapy
- Therapeutic Targeting of the Melanoma Stem Cell Population
- Pigmentation Pathways and Microphtalmia-Associated Transcription Factor as New Targets in Melanoma
- Understanding Interferon: Translating Biologic Advances into Clinical Progress
- Predicting and Increasing Response of Melanoma to Interferon Therapy
- New Approaches for Optimizing Melanoma Vaccines
- Adoptive T Cell Immunotherapy
- Procurement of Human Melanoma Specimens for Translational Research: Practical and Legal Considerations
Index